Key Strategies to Drive Innovation in Discovery
Investment in biopharmaceutical R&D remains high, reflecting a solid commitment to innovation in the field. The rapid expansion of monoclonal antibodies, antibody-based therapies (e.g., antibody-drug conjugates, bispecific, multispecific), and cell and gene therapies shows how the industry is pushing the boundaries of drug discovery. However, significant challenges persist, such as lengthy development timelines, high R&D costs, and low approval rates.
This ebook serves as a guide to enhancing this process and accelerating the discovery of novel biotherapeutics through key strategies including the adoption of AI, leveraging SaaS and facilitating data sharing and collaboration.